z-logo
Premium
Side effects of HIV therapy
Author(s) -
Esser Stefan,
Helbig Doris,
Hillen Uwe,
Dissemond Joachim,
Grabbe Stephan
Publication year - 2007
Publication title -
jddg: journal der deutschen dermatologischen gesellschaft
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.463
H-Index - 60
eISSN - 1610-0387
pISSN - 1610-0379
DOI - 10.1111/j.1610-0387.2007.06322.x
Subject(s) - lipodystrophy , medicine , lipoatrophy , mitochondrial toxicity , nucleoside reverse transcriptase inhibitor , regimen , antiretroviral therapy , drug , immunology , immune system , protease inhibitor (pharmacology) , reverse transcriptase , dermatology , human immunodeficiency virus (hiv) , pharmacology , viral load , biology , rna , biochemistry , gene
Summary The use of highly active effective antiretroviral therapies (ART) has dramatically decreased the morbidity and mortality of the HIV infection. Over 20 anti‐retroviral substances are available in four different classes. Side effects of HIV therapy are common and may influence the prognosis, as the medications are required lifelong for the still incurable infection. ART‐associated allergic reactions, lipodystrophy syndrome and immune reconstitution syndrome are side effects frequently seen by dermatologists. Exanthems are challenging as drug reactions must be separated from immune reconstitution, syphilis and viral exanthems and then the causative agent must be identified from a long list of medications. Non‐nucleoside reverse transcriptase inhibitors typically cause allergic exanthems. Mitochondrial toxicity caused by nucleoside reverse transcriptase inhibitors is responsible for lipoatrophy and fatty changes in the liver. Protease inhibitors cause diarrhea, abnormalities of glucose and fat metabolism and lipohypertrophy. Before other medications or surgical measures are undertaken to address side effects of ART, the regimen should be adjusted to include alternative but equally effective agents.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here